Seres Therapeutics (MCRB) Times Interest Earned: 2020-2024
Historic Times Interest Earned for Seres Therapeutics (MCRB) over the last 3 years, with Mar 2024 value amounting to -$55.72.
- Seres Therapeutics' Times Interest Earned fell 53.83% to -$55.72 in Q1 2024 from the same period last year, while for Mar 2024 it was -$8.72, marking a year-over-year increase of 68.42%. This contributed to the annual value of -$79.05 for FY2023, which is 164.51% down from last year.
- As of Q1 2024, Seres Therapeutics' Times Interest Earned stood at -$55.72, which was down 458.60% from $15.54 recorded in Q2 2023.
- In the past 5 years, Seres Therapeutics' Times Interest Earned registered a high of $91.94 during Q3 2021, and its lowest value of -$66.98 during Q4 2021.
- Its 3-year average for Times Interest Earned is -$30.70, with a median of -$36.23 in 2023.
- Data for Seres Therapeutics' Times Interest Earned shows a peak YoY increase of 323.77% (in 2021) and a maximum YoY decrease of 184.05% (in 2021) over the last 5 years.
- Seres Therapeutics' Times Interest Earned (Quarterly) stood at -$23.58 in 2020, then tumbled by 184.05% to -$66.98 in 2021, then spiked by 98.63% to -$0.92 in 2022, then surged by 136.83% to $15.54 in 2023, then crashed by 53.83% to -$55.72 in 2024.
- Its last three reported values are -$55.72 in Q1 2024, $15.54 for Q2 2023, and -$36.23 during Q1 2023.